483
GUANGDONG BIOLIGHT MEDITECH CO., LTDFDA 483 - GUANGDONG BIOLIGHT MEDITECH CO., LTD - September 05, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of GUANGDONG BIOLIGHT MEDITECH CO., LTD, a class II medical device manufacturer in Zhuhai, Guangdong, China, revealed two significant observations. The firm lacked adequate procedures for design changes, specifically regarding software compilation and bug mitigation for their pulse oximeters. Additionally, the company failed to establish procedures to justify sampling sizes used in design and process validation/verification activities.
Open in Dashboard
ID · 6e9fddb7-f444-4c46-96e9-913fcb96bffe